Likewise, non-endometrioid and recurrent tumors displayed higher cfDNA levels, although the results did not reach statistical significance ( Figure 3 A, Table 2 ).
← all excerpts
Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer.
1
—
—